E. Jay Wilusz
Patent Attorney, Attorney at Law
Massachusetts
NJ, WA, Patent Bar
School of Law
"Jay is a very good communicator and very honest. Would highly recommend."
About
clients
upcounsel
experience
Practice Areas
Client Reviews
"Jay is a very good communicator and very honest. Would highly recommend."
Posted on Jul 27, 2017
"Jay did an amazing job on my utility patent. He will always go out of his way to be as descriptive and clear as possible for any questions you ask. I would recommend him every time. I will continue to use jay throughout the stages of the patent process. "
Posted on Jun 19, 2017
"Jay was great all-around. He was very fair, very thorough, and easy to communicate with."
Posted on Apr 12, 2017
"Jay went over and beyond for the patent - extremely professional and knowledgeable. We never had a problem getting a hold of him. He converted it from where it was at to completion. Thorough job. "
Posted on Mar 30, 2017
"Jay was very helpful and knowledgeable about the details I needed to file my Non-Provisional Patent application. "
Posted on Mar 29, 2017
"My overall experience with E. Jay was good and informative. I appreciated all that he did to help me."
Posted on Mar 28, 2017
Work History
EJW Pharma Strategy LLC
Principal and Founder
Jul 2012 - Present
• Advise pharma companies on business development, IP, regulatory, and licensing strategies.
• Design and implement IP, legal, marketing, business development and regulatory opportunities for Life Science products.
• Completed license deal of multiple products for 400 MM USD for a top 5 global Life Science company.
• Implement new development and marketing plans for Sanofi TB drug, Priftin®.
Sanofi
US Life Cycle Management Oncology and Multiple Sclerosis Franchises Lead
Oct 2010 - Jun 2012
• Led teams of multi-functional experts to develop exclusivity for Aubagio®, Lemtrada®, Jevtana®, and Elitek®, via indications, drug delivery, drug repurposing and adherence projects.
• Appraised biotechnology and asset values for the acquisition of Genzyme.
• Implemented biotech strategy and due diligence for US and EU product development and marketing.
• Negotiated licensing agreement terms.
Novartis Pharmaceuticals
Vice President, Pharma Regions Counsel, No. & So. America & Japan, Pharma IP Dept.
Jun 2001 - Aug 2010
• Obtained product patent protection, asset licenses, IP rights and rendered opinions for products with sales of 15+ Billion USD.
• Successful litigation outcome for products worth 1+ Billion USD.
• Negotiated IP protection and exclusivity with government entities and organizations in US, CA, LatAm and Japan.
• Implemented strategy, initiatives, and financial controls for 25 member IP staff.